Abstract
When given orally in combination with l‐cysteine, 5′‐deoxy‐5‐fluorouridine (DFUR) brought about a significant reduction in the growth of adenocarcinoma 755 and a significant prolongation of life‐span in mice bearing Lewis lung carcinoma without increased toxicity to the host as compared with DFUR alone, though l‐cysteine alone did not show an appreciable antitnmor activity. Moreover, the combination of DFUR and l‐cysteine resulted in a marked retardation of growth of human colon tumor LS174T transplanted into nude mice. Thus, the potency of DFUR was increased by l‐cysteine. Pharmacokinetic studies revealed that after DFUR administration, plasma DFUR and 5‐fluorouracil (5‐FU) levels rapidly declined, but that, in the combination with l‐cysteine, the plasma clearances of DFUR and 5‐FU were slowed down considerably. In the tumor, DFUR and 5‐FU levels were similar to those in the plasma. Such a prolongation of DFUR and 5‐FU levels in plasma and tumor may produce the enhancement of antitumor effect seen with the combination of DFUR and l‐cysteine.
Keywords: 5′‐Deoxy‐5‐fluorouridine, L‐Cysteine, Antitumor activity, Combination therapy
Full Text
The Full Text of this article is available as a PDF (307.8 KB).
REFERENCES
- 1. ) Iigo , M. and Hoshi , A.Mechanism of potentiation of antitumor activity of 5‐fluorouracil against adenocarcinoma 755 by L‐cysteine . Biochem. Pharmacol. , 35 , 727 – 730 ( 1986. ). [DOI] [PubMed] [Google Scholar]
- 2. ) Iigo , M. , Nakajima , Y. , Hoshi , A. and De Clercq , E.Enhancing effect of bromovinyldeoxyuridine on antitumor activity of 5‐fluorouracil and ftorafur against adenocarcinoma 755 in mice . Eur. J. Clin, Oncol. , 23 , 773 – 777 ( 1987. ). [DOI] [PubMed] [Google Scholar]
- 3. ) Iigo , M. , Hoshi , A. and Kitagawa , H.Potentiation of the chemotherapeutic action of tegafur against solid adenocarcinoma 755 by combination with l‐cystine . J. Cancer Res. Clin. Oncol. , 111 , 187 – 190 ( 1986. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4. ) Iigo , M. , Araki , E. , Nakajima , Y. , Hoshi , A. and De Clercq , E.Enhancing effect of bromovinyldeoxyuridine on antitumor activity of 5‐fluorouracil against adenocarcinoma 755 in mice. Increased therapeutic index and correlation with increased plasma 5‐fluorouracil levels . Biochem. Pharmacol. , 37 , 1609 – 1613 ( 1988. ). [DOI] [PubMed] [Google Scholar]
- 5. ) Iigo , M. , Yamaizumi , Z. , Nishimura , S. , Hoshi , A. and De Clercq , E.The antitumor potency of oral tegafur against adenocarcinoma 755 in mice is markedly enhanced by oral (E)‐5‐(2‐bromovinyl)‐2′‐deoxyuridine . Jpn. J. Cancer Res. , 78 , 409 – 413 ( 1987. ). [PubMed] [Google Scholar]
- 6. ) Murinson , D. S. , Anderson , T. , Schwartz , H. S. , Myers , C. E. and Chabner , B. A.Competitive binding radioassay for 5‐fluorodeoxyuridine 5′‐monophosphate in tissues . Cancer Res. , 39 , 2471 – 2475 ( 1979. ). [PubMed] [Google Scholar]
- 7. ) Danysz , A. , Wierzba , K. , Wutkiewics , M. , Pniewska , A. and Praglowski , T.The effect of some sulfhydryl compounds on the toxicity of 5‐fluorouracil and 6‐mercaptopurine in laboratory animals . Acta Pol. Pharm. , 41 , 571 – 574 ( 1984. ). [PubMed] [Google Scholar]
- 8. ) Yoshimura , K. , Iwauchi , Y. , Sugiyama , S. , Kuwamura , T. , Odaka , Y. , Satoh , T. and Kitagawa , H.Transport of L‐cysteine and reduced glutathione through biological membranes . Res. Commun. Chem. Pathol Pharmacol. , 37 , 171 – 186 ( 1982. ). [PubMed] [Google Scholar]
- 9. ) Jones , M. E.Pyrimidine nucleotide biosynthesis in animals: genes, enzymes, and regulation of UMP biosynthesis . Ann. Rev. Biochem. , 49 , 253 – 279 ( 1980. ). [DOI] [PubMed] [Google Scholar]
- 10. ) Christopherson , R. I. and Jones , M. E.The overall synthesis of L‐5,6‐dihydroorotate by multienzymatic protein pyr1‐3 from hamster cells . J. Biol. Chem. , 255 , 11381 – 11395 ( 1980. ). [PubMed] [Google Scholar]